MedTrace Logo

Interactive Voice Based Administration of the GAD 7

NCT04990492 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2022-04-21

No results posted yet for this study

Summary

This study investigates a new delivery method for the General Anxiety Disorder - 7 (GAD 7), a clinically accepted tool for diagnosing general anxiety disorder. The new tool records auditory responses to the assessment and the study will examine if the instrument is effective at capturing participant depression levels. If proven effective, future studies may investigate if the new format can be used to improve at home clinical care.

Conditions

  • General Anxiety Disorder

Interventions

DIAGNOSTIC_TEST

Paper GAD 7

The paper based GAD 7 that is commonly accepted at clinics

DIAGNOSTIC_TEST

Voice Administered GAD 7

This is the voice based GAD 7 that is administered through a Mirror device equipped with Amazon Alexa software.

Sponsors & Collaborators

  • Oral Roberts University

    collaborator UNKNOWN

  • Oklahoma State University Center for Health Sciences

    lead OTHER

Principal Investigators

  • Jason Beaman, D.O. · Oklahoma State University Center for Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-10
Primary Completion
2022-05-31
Completion
2022-06-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04990492 on ClinicalTrials.gov